Global Antibody Market Growth 2023-2029

Global Antibody Market Growth 2023-2029

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

LPI (LP Information)' newest research report, the “Antibody Industry Forecast” looks at past sales and reviews total world Antibody sales in 2022, providing a comprehensive analysis by region and market sector of projected Antibody sales for 2023 through 2029. With Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody industry.

This Insight Report provides a comprehensive analysis of the global Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody.

The global Antibody market size is projected to grow from US$ 8893.3 million in 2022 to US$ 12940 million in 2029; it is expected to grow at a CAGR of 12940 from 2023 to 2029.

Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.

In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibody market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

IgM

IgG

IgA

Other

Segmentation by application

Therapeutic

Research

Diagnostic

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Roche

Johnson and Johnson

Merck

Novartis

AbbVie

Amgen

Pfizer

Bayer

Lilly

Bristol-Myers Squibb

GlaxoSmithKline

Biogen

AstraZeneca

Sanofi

Alexion Pharmaceuticals

Seattle Genetics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Antibody market?

What factors are driving Antibody market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Antibody market opportunities vary by end market size?

How does Antibody break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.